Almost a third (32 of every 100) of older adults infected with COVID-19 in 2020 developed at least one new condition that required medical attention in the months after initial infection, 11 more than those who did not have ...
Feb 9, 2022
1
352
Inflammation is a defense mechanism of the body to fight pathogens. However, when it is widespread and excessive, it can aggravate the pathology and even cause death. One of the ways in which this excessive response occurs ...
Jan 31, 2022
0
16
(HealthDay)—For patients with hematologic malignancies, septic shock is associated with high mortality rates and poor 90-day survival, according to a study published in the January issue of the Journal of the National Comprehensive ...
Jan 26, 2022
0
9
(HealthDay)—A review of cases from 465 U.S. hospitals underscores the protection provided by COVID-19 vaccines.
Jan 10, 2022
0
44
One of the long-term impacts observed during the COVID-19 pandemic stems from patients being intubated and breathing from a ventilator for an extended period of time. These patients usually undergo a procedure known as a ...
Jan 3, 2022
0
32
"We are inundated," Antonino Marchese says wearily as his Rome COVID hospital fills up with patients, most of them unvaccinated despite tougher restrictions for Italians who are not jabbed.
Dec 30, 2021
0
7
Until her clinical rotation in the earliest months of the COVID-19 pandemic, Valeria Valbuena, M.D., then a surgical resident at University of Michigan Health, had never seen so many patients who looked like her on the intensive ...
Oct 28, 2021
0
3
Unwell COVID-19 patients may be treated just as effectively with oxygen through a mask rather than the sometimes difficult to tolerate therapy known as Continuous Positive Airway Pressure (CPAP), according to a new study.
Sep 8, 2021
1
7
No benefit of high-flow therapy (HFT) can be derived from the available study data for patients with advanced chronic obstructive pulmonary disease (COPD) or chronic type 1 respiratory failure. It therefore remains unclear ...
Jul 20, 2021
0
2
A repurposed arthritis drug has shown positive results in a clinical trial of patients hospitalized with COVID-19, according to a paper published Wednesday in the New England Journal of Medicine.
Jun 17, 2021
0
7
